Abstract:Key PointsHigh-resolution structures have recently revealed the subunit and domain organization of the influenza A, influenza B and influenza C virus RNA polymerases. The polymerase basic 1 (PB1) subunit together with the C-terminal domain of polymerase acidic (PA) and the N-terminal one-third of PB2 form the core of the polymerase, which is decorated by several flexible domains, including the PB2 cap-binding and PA endonuclease domains.Crystal structures obtained in the absence and presence of viral genomic RNA have captured the influenza virus RNA polymerase in transcriptionally inactive and transcription pre-initiation states, showing a different arrangement of the peripheral PB2 cap-binding and PA endonuclease domains and suggesting a mechanism for the activation of the cap-snatching function of the polymerase.Structural and biochemical analyses have identified the binding sites of the 5′ and 3′ termini of viral RNAs, the template entry and exit channels, the substrate entry and product exit channels, the polymerase active site and a priming loop.Based on the high-resolution structural information about the influenza virus RNA polymerases, the models for viral transcription and genome replication have been revised.Viral and host factors participate in the regulation of viral transcription and genome replication. However, in many cases, the underlying molecular mechanisms remain unknown.Understanding how the influenza virus RNA synthesis machine works at the molecular level and knowledge of its interaction with viral and host factors might lead to the identification of targets that could be exploited for the development of antivirals to prevent or treat influenza virus infections.

Viral RNA Polymerase: A Promising Antiviral Target for Influenza A Virus

RNA Polymerase As a Promising Target for Anti-Influenza Virus Agents

Influenza A Virus Polymerase: an Attractive Target for Next-Generation Anti-Influenza Therapeutics

Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza

Potential targets and their relevant inhibitors in anti-influenza fields.

Emerging antiviral therapies and drugs for the treatment of influenza

Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis

Progress Of Small Molecular Inhibitors In The Development Of Anti-Influenza Virus Agents

A Parallel Phenotypic Versus Target-Based Screening Strategy For Rna-Dependent Rna Polymerase Inhibitors Of The Influenza A Virus

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance

Current and novel antiviral strategies for influenza infection

Influenza virus polymerase inhibitors in clinical development

RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication

Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins

Polymerase Structure And Function

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

Identification of influenza A nucleoprotein as an antiviral target

795. RNA Interference of Influenza Virus Infection

Antiviral strategies against influenza virus: towards new therapeutic approaches

Rational Design and Optimization of Acylthioureas As Novel Potent Influenza Virus Non-Nucleoside Polymerase Inhibitors.

Discovery of Aryl Benzoyl Hydrazide Derivatives As Novel Potent Broad-Spectrum Inhibitors of Influenza A Virus RNA-Dependent RNA Polymerase (Rdrp)